Every fact traced to its source, and checked against it. Explore the companies, facts, and conclusions behind the news.
Conclusions our AI is drawing from the traced facts — read them as interpretation, each grounded in the data and the entities it names.
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Enterprise software is shifting toward autonomous, agent-driven platforms. SAP (Autonomous Enterprise), Zeta (AthenaOS, Athena MCP and the AIM inference model) and Meta (Enterprise Platform, with MongoDB's CEO moving over) are all building agent platforms. Smaller deals show the supporting layers being bought up: Tiny acquired Oso Cloud (authorization), Harvey acquired Guardrails AI, and Latitude and Dextr AI raised seed and Series A rounds. Investor commentary (Norwest's Sean Jacobsohn) says finance is the most promising area to disrupt, though AI can't be trusted with calculations. EDB argues that governance must be enforced by the system rather than left to the agent.
Hardware vendors are racing to standardize and scale AI infrastructure. Cisco and NVIDIA plan an open 400G-per-lane optics spec, Cisco announced open AI silicon, systems and optics at OCP 2026, and Marvell launched its second-generation Structera X parts. Samsung's forecast of record quarterly profit and Acer's warning about Micron's price increases show the buildout feeding through to memory and component costs. At the software layer, Zeta's Athena stack (AthenaOS, AIM, MCP) pushes intent-driven AI into enterprise software. OpenAI is under scrutiny: its safety transparency lead quit, and Mark Chen defended its training monitors and predicted open-source models with similar capabilities within a year.
Analysts are growing more cautious on aerospace and defense. J.P. Morgan's Seth Seifman downgraded Leidos to Neutral and cut its target on 8 Oct, and he cited weak Q3 sentiment, weaker Boeing 2027 cash-flow expectations and federal budget uncertainty after the 3 Nov midterms. Bullish calls are concentrating on AI-linked infrastructure and speculative tech: Bank of America on NuScale, Lynx on Micron and Sandisk, and Bloom's dispatchable power. D-Wave is the exception, with a 171x price-to-sales multiple flagged as stretched. Consumer and financial names (Wendy's, Capital One, Levi's) show a split, and the K-shaped economy and SpaceX's drop of more than 40% from its highs point to selective risk appetite.
CFOs are changing seats (Rivian to GE Vernova, PJT Partners, Penguin Solutions) and running a dense autumn calendar of earnings, investor days and debt refinancings. At the same time, finance functions are moving toward agentic AI: PwC and SAP extended their AI collaboration, Harvey acquired Guardrails AI, and Morgan Foods is preparing for agentic adoption. In banking, CFOs such as Origin's, BankUnited's and Donald Hinson's describe stable-to-improving net interest margins but stiffer deposit competition and the coming Durbin Amendment impact in mid-2027.
Oncology is in a dense Q4 2026 catalyst window. The FDA approved Tecentriq in adjuvant dMMR colon cancer and set a PDUFA date of 2026-11-14 for ivonescimab. Personalized mRNA vaccines (intismeran) and bispecific, ADC and protein-degrader combinations (ivonescimab plus Datroway, bexobrutideg) are advancing alongside new trial collaborations. At the same time, AstraZeneca executives describe AI-designed biologics and automated labs as the next productivity lever, and McKesson/CD&R's Option Care Health acquisition and Novocure's record quarter show capital moving into oncology services and commercial delivery.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Samsung will likely announce a unified smart home AI platform or hub within 2-3 months that connects these disparate AI-enabled products
Sustained AI feature expansion across Samsung ecosystem in Q1-Q2 2026, with likely follow-up announcements for mobile devices and additional appliances
NVIDIA GPU acceleration is becoming the dominant infrastructure for AI chip design and EDA workflows, creating a self-reinforcing ecosystem where AI chips are designed using AI-accelerated tools
88% confidence · untestedData center infrastructure investments are shifting from traditional cloud providers to AI-specific facilities, with hyperscalers willing to commit $20B+ multi-year contracts for AI-optimized data center capacity, creating opportunities for specialized infrastructure developers
88% confidence · untestedLLM sycophancy is primarily caused by reinforcement learning from human feedback (RLHF) optimization for user approval rather than truthfulness, creating a systematic bias that degrades model reliability in extended conversations
85% confidence · untestedHyperscaler AI infrastructure investments exceeding $200B combined will drive semiconductor demand and AI chip production capacity expansion in 2026
85% confidence · untestedAI safety concerns are escalating as models gain access to classified and sensitive data, creating new security vulnerabilities and ethical challenges around training data governance
85% confidence · untestedDC judge delivers smackdown to Airbnb squatter after ruling she has no tenancy. Homeowner rights finally defended?
“DC judge delivers smackdown to Airbnb squatter after ruling she has no tenancy. Homeowner rights finally defended? 7 News Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…”
Marketing Technology (MarTech) Market Worth USD 3.28 Trillion by 2035 Driven by AI, Agile Marketing, and Privacy-First Personalization
“Marketing Technology (MarTech) Market Worth USD 3.28 Trillion by 2035 Driven by AI, Agile Marketing, and Privacy-First Personalization Ottawa, Feb…”
Crypto Casinos 2026: Thunderpick Expands Worldwide with Provably Fair Games, Instant Payouts & Betting Options
“Crypto Casinos 2026: Thunderpick Expands Worldwide with Provably Fair Games, Instant Payouts & Betting Options New York City, NY, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Waiting too long for your crypto withdrawals to clear?…”
Tech stocks today: Nvidia invests $4B in photonics makers, Apple announces low-cost iPhone, OpenAI strikes deal with Pentagon
“Tech stocks today: Nvidia invests $4B in photonics makers, Apple announces low-cost iPhone, OpenAI strikes deal with Pentagon Artificial intelligence leader Nvidia (NVDA) announced two new $2 billion investments into Coherent (COHR) and Lumentum (LITE), whose stocks jumped on Monday, as the AI giant looks to scale up i…”
Aptiv Q4 Earnings Call Highlights
“Aptiv Q4 Earnings Call Highlights Aptiv logo 3 Stocks Powering the Future of Autonomous Driving Aptiv (NYSE:APTV) reported record fourth-quarter revenue and outlined its 2026 outlook during its Q4 2025 earnings call, highlighting continued progress in expanding beyond automotive markets and preparing for the planned Ap…”
Video Friday: Autonomous Robots Learn By Doing in This Factory
“IEEE Spectrum - Technical Title: Video Friday: Autonomous Robots Learn By Doing in This Factory Date: 2026-02-06 17:00 Source: https://spectrum.ieee.org/autonomous-warehouse-robots <img src="https://spectrum.ieee.org/media-library/robotic-arms-on-mobile-bases-sort-crates-on-a-conveyor-belt-in-a-warehouse.png?id=6390782…”
Two different margin values (16% vs 18%) are recorded for the same entity (Shopify Inc.) at the identical timestamp (2026-08-05 00:00:00). With no distinguishing context (same period designation, no qualifier for margin type), these represent conflicting data about the same fact.
Fact B (Q1 2026) and Fact A (Q2 2026) are recorded as observed on the same date: 2026-03-29. This is temporally impossible, since Q2 2026 (April–June) has not yet occurred as of 2026-03-29 (mid-Q1). Financial results for a future period cannot be observed before that period ends. Additionally, 3.7 USD is implausibly low as a cash position for Qualcomm Incorporated, suggesting a data entry error in Fact B.
Both facts measure EPS for Citigroup with identical observation dates (2025-12-31). FACT A explicitly specifies FY 2025 annual EPS at 6.99 USD/share, while FACT B reports 1.65 USD with an unspecified fiscal period (N/A). The values differ by a factor of ~4.2x, which is too large to explain by rounding, methodology, or data quality variance. While FACT B's 'N/A' fiscal period introduces ambiguity about whether it represents the same annual period, both observations are timestamped identically and purport to measure the same metric on the same date. If both represent FY 2025 annual EPS, this is a direct value conflict. If FACT B represents a different period (e.g., quarterly, TTM, or interim), the ambiguous labeling still constitutes a data quality issue that obscures the reconciliation.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
Both facts measure the same attribute (cash) for the same entity (Tesla Inc.) at the same point in time (2025-12-31). Although labeled with different fiscal period categories (FY 2025 vs Q4 2025), both periods end on the same date, making them equivalent time snapshots. The values differ drastically: $16.513 billion vs $44.06 USD. Since Q4 2025 is the final quarter of FY 2025, both should report identical cash balances at period-end. A 375 million-fold magnitude difference indicates a real contradiction, likely caused by a data quality issue (unit error, miscategorization, or source error in FACT B).
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Every fact is traceable to the document it came from — see how we source every claim.
A Tecentriq approval, a 14 November FDA deadline for Summit's ivonescimab and Novocure's record quarter make this a decisive stretch for cancer medicine. Summit's SEC-verified accounts show how costly the wait has been. The AI claims behind the sector's next leap come from a source our checks rate poorly.
Two dated events will test oncology's new tools within weeks: Merck and Moderna's personalized mRNA vaccine data at ESMO on Oct. 24, and the FDA decision on Summit's ivonescimab on Nov. 14. We checked Merck's SEC-filed numbers and flag where the sources are weak.
SEC-filed figures show Micron's capital spending roughly doubled in fiscal 2025 and its cash pile has since more than doubled in a year. Analysts back the AI-infrastructure names while flagging a 171x sales multiple at D-Wave and a split consumer. We also show how reliable each source is.
SEC filings show Micron's capital spending nearly doubled in fiscal 2025 and its cash pile has grown to about $25 billion. Analysts expect the AI chip shortage to last 12 to 18 months. We checked the numbers against filings and flagged where the analyst claims rest on weaker sources.
A survey reported by MIT Technology Review finds every respondent plans to use agentic AI within two years, yet AI reaches only part of company data. Money is moving to governance and data plumbing. We checked the figures, and the survey piece itself scores poorly on source reliability.
Several well-known companies announced new chief executives or CEO searches between July and early October 2026. Via News checked each against its source. The handoffs are mostly orderly, but one departure was abrupt, one company is still searching, and the sources' accuracy records vary widely.
Meta's new enterprise platform will be led by MongoDB's departing CEO, while small AI-native startups raise funding. Investors say back-office finance software is next, but one of them warns AI is bad at maths. We flag which sources are weaker and which parts of the story our evidence cannot yet support.
A survey says 100% of organizations plan to use AI agents within two years, yet only about 45% of company data is AI-accessible. We checked the claims against sources, and the survey's publisher scored poorly on reliability, so we flag that. Nvidia's SEC-verified costs show the build-out is real.
A personalised mRNA vaccine from Merck and Moderna stopped melanoma returning in a trial, and AstraZeneca is betting AI can speed up drug design. Via News checked what the record supports: some of the optimism rests on firm data, and some on sources that failed our own reliability tests.
Verified SEC figures show Nvidia's cost of revenue rose about 3.8 times in two fiscal years. A survey says every respondent plans to use AI agents, but company data and trust lag. That survey's source failed our check on all 11 claims we tested, so we flag it and lean on the data that held.
SEC-filed figures show Micron nearly doubled its capital spending in fiscal 2025 and now holds about 2.5 times the cash it had a year earlier. Analyst enthusiasm for power, data-center and quantum stocks rests on sources that held up only about half the time in our checks.
Companies from Manulife to Box customers are rolling out AI agents, and funding is flowing. But a trade-press study reports that in 'data laggard' firms, AI can reach 30% or less of company data. That source has a poor measured record, so we flag it as a claim, not a fact.
Every company surveyed by MIT Technology Review plans to use AI agents within two years, yet firms with weak data give those agents access to 30% or less of it. Only some of this is firmly established: that survey's source scores 0% on our reliability check, and the Nvidia figures are SEC-verified.
Adobe's weak guidance, Alphabet's negative free cash flow, and a wave of safety-driven departures from Anthropic, Google and OpenAI show investors and insiders both demanding proof, not promises — even as California moves first to regulate AI's reach into children's lives.
A single summit produced roughly $950 billion in AI infrastructure deals and locked Nvidia into South Korea's memory supply chain, while one research firm says Wall Street is still underpricing the memory chip boom behind it. Here's what's verified, what's just one analyst's call, and what's still speculative.
C3.ai's CEO sold $4.8 million in stock the same week the industry's biggest AI-agent-trust survey turned out unreliable on 11 checked claims, even as Manulife, Box and a wave of banking and healthcare startups commit real budgets. Via News separates the verified from the unverified.
Google now lets users strip visible watermarks from Gemini-made images, video and music — a move that cuts against the story of an industry rushing toward stronger AI-content labeling, and lands the same week OpenAI lost another senior executive.
Nvidia and South Korea's chipmakers signed roughly $950 billion in new AI agreements in July, including a deal to help secure Nvidia's HBM memory supply from SK Hynix, even as chip stocks logged a sharp correction and the Nasdaq 100 hit a 2.75-month low. Via News traces the deals, earnings and balance-sheet data behind the divergence.
A late-July selloff cut deep into AI-chip stocks — Micron fell nearly 40% from its peak — even as Nvidia expanded its SK hynix memory deal, GlobalFoundries signed a $300M federal photonics award, and Skyworks-Qorvo named a combined leadership team. The data show a maturing boom repricing risk, not a broken one.
Nearly all enterprises surveyed say they'll deploy AI agents within two years, but agents can typically reach under half of company data — and as little as 30% at 'data laggard' firms. Platform giants are selling governance; a new wave of startups is skipping the data problem by targeting narrow, auditable back-office tasks instead.
Brad Lightcap, OpenAI's special projects lead and the company's former chief operating officer, has announced his departure from the company.
Insurer Manulife, software firm Box and data platform Snowflake are each rolling out enterprise AI agent tools this year, spanning insurance, content management and data operations worldwide. A fintech startup, Casap, is building agents for dispute resolution, while enterprise leaders across regions report unclear governance for the technology.
Micron and SanDisk are among 2026's top-performing chip stocks on AI memory demand, but both have fallen sharply from June record highs. Figures dated and sourced.
Jeff Dean and Sanjay Ghemawat quit Google within the same week to launch startup Discovery Loop, while Demis Hassabis stepped back from running DeepMind. Alphabet responded by investing in the new venture rather than treating the exits as a pure loss, a hedging strategy now spreading across global AI markets.
Oriol Vinyals, co-leader of Google's Gemini models, has left to co-found Discovery Loop, a new frontier AI venture. The move puts a veteran of one of the world's best-funded AI labs into a startup that must build compute, capital and talent from scratch amid intense global competition.
Bloom Energy signed a $1.7 billion fuel-cell agreement with Nebius AI, one of the largest on-site power deals for AI data centers to date. The company also struck a deal with utility giant AEP and expanded distribution in South Korea, showing on-site generation is now a global bottleneck for AI buildout.
Every fact here is structured and source-traced — so AI systems inherit ground truth, not re-narrated claims. The same facts a person reads, a model can query.